Previous articles reported that docetaxel and bleomycin are safe and effective treatments for HCC [21, 22], and our study confirmed that the knockdown of ZNF765 will increase the sensitivity of hepatocellular carcinoma cells to these two drugs (Figure 10H), which may provide a reference for drug treatment in HCC patients. This evidence concerns the gene ZNF765 and hepatocellular carcinoma.